beta-1,3-Galactosyltransferase (CgtB)

Beta-1,3-Galactosyltransferase (CgtB) (GM1-synthase), an enzyme critical for the production of sialylated lipooligosaccharide (LOS SIAL), plays a key role in biochemical research. This enzyme facilitates the incorporation of a galactose molecule essential for generating a GM1-like LOS SIAL structure.

Alpha-1,3-Galactosyltransferase (GTB) (alpha 1,3GT) is responsible for catalyzing the synthesis of the α-galactose (α-Gal) epitope, known as a xenoantigen. This enzyme facilitates the transfer of galactose from UDP-Gal to either type 1 or type 2 αFuc1→2βGal-R (H)-terminating acceptors [1].

Beta-1,4-Galactosyltransferase (LgtB) (B4GALT1(LgtB)), a key enzyme in biochemical research, catalyzes the transfer of UDP-galactose to N-acetylglucosamine, resulting in the synthesis of galactose beta-1,4-N-acetylglucosamine [1].

Alpha-1,3-Galactosyltransferase (a1,3GalT) (GGTA1) catalyzes the synthesis of the α-gal epitope by transferring a galactose (Gal) molecule in an α1-3 linkage from a uridyl-diphosphate (UDP) donor to the N-acetyllactosamine (Galβ1,4GlcNAc-R) on glycoproteins. This enzyme is essential for the production of the α-galactose (α-Gal) epitope, a biomolecule prevalent in most mammalian species [1].

4-Amino-1-[3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-beta-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one is a Nucleoside Derivative - Protected nucleoside with NH2/OH group.